stella
beta
A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC — Stella
Home
/
Lung Cancer, Non-Small Cell
/
View on ClinicalTrials.gov
Recruiting
Back to Lung Cancer, Non-Small Cell trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
West China Hospital, Sichuan University, Chengdu, Sichuan